Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke (ACTION)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Biogen Idec
ClinicalTrials.gov Identifier:
NCT01955707
First received: September 30, 2013
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)